Drugs / BBI-5000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02590289 | Oct → Dec 2015 | atopic eczema | Fresh Tracks Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BBI-5000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02590289 ↗ |
| Route | Oral | “single oral dose of BBI-5000” NCT02590289 ↗ |